Semaglutide, a drug commonly known as Ozempic, has been approved by the U.S. Food and Drug Administration to treat Type 2 diabetes since 2017.[0] However, during pre-approval studies, researchers noticed a remarkable side effect: people lost weight.[1] This led to the 2021 FDA approval of Wegovy, a higher dosage of semaglutide, for people with obesity […]
Continue readingThe diabetes drug Ozempic, whose generic name is semaglutide, has become increasingly popular in recent months, not just for treating type 2 diabetes but also for its weight loss benefits.[0] Ozempic is an injectable medication manufactured by Novo Nordisk that contains semaglutide, a hormone that helps regulate insulin and suppress appetite. The drug was approved […]
Continue reading